$1.750
+0.117 (+6.71%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PPCB Prediction & Forecast by Similar Chart Analysis
Alphio's PPCB stock price prediction model matches the current Propanc Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.73 (-0.97%). The 1-week path is $1.81 (+3.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Propanc Biopharma Inc Stock?
Propanc Biopharma Inc (PPCB) is not a good buy right now. The current price is $1.75, which is significantly down 98.78% year-to-date and 99.22% over the past year. The RSI is at 27.15, indicating that the stock is oversold, but the forward P/E ratio is 0, suggesting no earnings growth is expected in the near future. The main risk is the company's negative net income, which reached -$63,603,336 in Q3 2025, indicating ongoing financial struggles.
PPCB stock price ended at $1.75 on Friday, after rising +6.71%
Propanc Biopharma Inc (PPCB) last closed at $1.75, gaining +6.71%. These facts feed the 1-day and 1-week PPCB price prediction above.
Forecast Drivers
Propanc Biopharma Inc (PPCB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PPCB, ranked by similarity.
Seasonality analysis for PPCB
Historically the probability of a positive November return for PPCB is 0.00%. August offers the highest probability of a positive month at 31.25%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.